Our client CeriBell had a successful IPO on NASDAQ

Today, we are very pleased to announce that CeriBell has successfully listed on the NASDAQ (ticker: CBLL). This milestone is a testament to CeriBell’s strength and growth potential, and highlights our close partnership over the past eight years.

We have been a strong supporter of CeriBell since its founding in 2014, working closely with them from the early stages of product design and development to supply chain optimization.

Our team leverages extensive industry knowledge and cutting-edge technology to tailor efficient and reliable supply chain solutions for CeriBell . This enables them to respond quickly to market demands and enhance their competitive advantage.

CeriBell's successful launch is a testament to the leadership and hard work of its founder and CEO, Dr. Xingjuan Zhao.

Under her leadership, CeriBell has become a leader in medical technology, especially with its innovative Ceribell platform. This AI-driven, real-time EEG diagnostic system is designed to rapidly diagnose neurological diseases in acute care settings.

CeriBell seamlessly combines portable hardware with advanced AI algorithms, greatly improving the accuracy and efficiency of diagnosis, bringing hope to patients around the world.

CeriBell's initial public offering was priced at US$17 per share, which soared to US$25 per share at the opening, a significant increase of 47.06% from the issue price, and a market value of US$850 million.

The outstanding performance attracted great attention from the market and made us more confident in CeriBell's prospects.

Looking back over the past eight years, our partnership with CeriBell has been a journey full of challenges and opportunities.

Together, we have witnessed CeriBell grow from a startup to a leading medical technology company, overcoming challenges and achieving success. This partnership has built trust and support, driving our mutual success.

In the future, we are committed to deepening our cooperation with CeriBell, providing more comprehensive and professional supply chain management services, and helping CeriBell advance in the field of medical technology.

We also look forward to working with more outstanding companies like CeriBell to create a better future.

Finally, we sincerely congratulate CeriBell on its successful listing on NASDAQ!

We hope that our cooperation will continue to flourish and we will achieve greater success together.